SCHEMBL24496097

SCHEMBL24496097

Cn1cnc(-c2cc(S(=O)(=O)NCC(F)(F)F)ccc2NCc2ccc(C(F)(F)F)cc2)c1

nearest known ligand 0.59

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ TEAD1 P28347 1/20 0.59
▸ YAP1 P46937 1/20 0.59
▸ TSHR P16473 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ CYP19A1 P11511 1/20 0.39
▸ SCN3A Q9NY46 1/20 0.39
▸ IDH2 P48735 10/20 0.38
▸ PTGS2 P35354 1/20 0.38
▸ TLR2 O60603 1/20 0.37
▸ TLR1 Q15399 1/20 0.37
▸ NPY5R Q15761 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ ASPH Q12797 1/20 0.36
▸ RIOX2 Q8IUF8 1/20 0.36
▸ KDM8 Q8N371 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29648384 1.00 TEAD1 (0.59) TEAD1YAP1TSHRL3MBTL1CYP19A1
SCHEMBL24496133 0.92 TEAD1 (0.60) TEAD1YAP1TSHRL3MBTL1CYP19A1
SCHEMBL24496265 0.90 TEAD1 (0.58) TEAD1YAP1TSHRL3MBTL1CYP19A1
SCHEMBL22718245 0.90 TEAD1 (0.74) TEAD1YAP1TSHRL3MBTL1CYP19A1
SCHEMBL24496334 0.88 TEAD1 (0.56) TEAD1YAP1TSHRL3MBTL1CYP19A1
SCHEMBL29648336 0.88 TEAD1 (0.56) TEAD1YAP1TSHRCYP19A1KMT2A
SCHEMBL24496011 0.88 TEAD1 (0.56) TEAD1YAP1TSHRCYP19A1KMT2A
SCHEMBL24496156 0.88 TEAD1 (0.56) TEAD1YAP1TSHRL3MBTL1CYP19A1
SCHEMBL24496033 0.88 TEAD1 (0.59) TEAD1YAP1TSHRL3MBTL1PTGS2
SCHEMBL29648345 0.88 TEAD1 (0.59) TEAD1YAP1TSHRL3MBTL1PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4281073-A1 COMBINATION OF A 3-(IMIDAZOL-4-YL)-4-(AMINO)-BENZENESULFONAMIDE TEAD INHIBITOR WITH AN EGFR INHIBITOR AND/OR MEK INHIBITOR FOR USE IN THE TREATMENT OF LUNG CANCER Ikena Oncology, Inc. (US) 2023-11-29 — — EP disclosed
WO-2022120355-A1 TEAD DEGRADERS AND USES THEREOF Ikena Oncology, Inc. (US) 2022-06-09 — — WO disclosed
WO-2022120353-A1 TEAD INHIBITORS AND USES THEREOF Ikena Oncology, Inc. (US) 2022-06-09 — — WO disclosed
Send feedback